Asarina Pharma
0.736 SEK +3.37%1 investor is following this company
Asarina Pharma is a Swedish pharmaceutical company focusing on pharmaceuticals for women's health. The company's main product, which is under development, is Sepranolone. Sepranolone is indicated for the treatment of PMDD, the most severe form of Premenstrual Stress (PMS). The company operates in the Nordic market. Asarina Pharma is headquartered in Solna.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
ASAP
Daily low / high price
0.66 / 0.756
SEK
Market cap
16.66M SEK
Turnover
14.05K SEK
Volume
19K
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Östersjöstiftelsen | 29.0 % | 29.0 % |
Kurma Biofund | 13.9 % | 13.9 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Bulletin from the Annual General Meeting of Asarina Pharma AB (publ)
ASARINA PHARMA AB (PUBL) ÅRDSREDOVISNING 2023 PUBLICERAD
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools